Ozmepic and Wegovy May Aid Bipolar Outcomes

A recent study has shown that weight loss medications containing the hormone "GLP-1," such as "Ozempic" and "Wegovy," reduce the risk of psychiatric hospitalization by 21% among individuals with bipolar disorder. These benefits are attributed to the ability of these medications to reduce inflammation and cellular stress in the brain, which contributes to mood stabilization. The findings suggest that these drugs may go beyond treating obesity and diabetes to offer potential benefits in managing bipolar disorder.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل